Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

By N. Tahara, H. Kai, M. Ishibashi, H. Nakaura, H. Kaida, K. Baba, N. Hayabuchi, T. Imaizumi. Journal of the American College of Cardiology, 2006

695 citations recorded by the source corpus.

Subfields: Cancer Research, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/81d04e535837c0f21f9a11232565b8a2c856f37f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Yancy
2. Rick A. Nishimura
3. Joshua A. Beckman
4. F. Kushner
5. Robert A. Guyton
6. C. Adams
7. H. Krumholz
8. G. Bakris

Citations in the corpus

• Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease (2010, methodology): “In conjunction with positron emission tomography it can be used to localize fluorodeoxyglucose uptake by the plaque, identifying active plaques and unstable plaques (577), but its clinical utility has yet to be established.”